The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
Please sign up for SocialPicks site access - it's free!

 Crucell NV  (CRXL) Trade Now »     Rate CRXL  -  Discuss CRXL  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
SocialPicks Sentiment:
N/A

** not enough data to be rated 		This Quarter's Sentiment:
All:
100.0%
Top:
100.0%
Rate CRXL:


Home
Analysis & Videos
Quotes
Bull or Bear
Discuss
        

CRXL: Bull or Bear? From:    SocialPicks  |  Blogsphere  |  All

SocialPicks Community

Crucell: An Excellent Shot at a Buyout Graphic_rating_buy CRXL
Mikerun
73%
 +18.59%
in 283 days
As the largest pure-play vaccine company with a market cap of $1.2B (U.S. Dollar), Crucell (CRXL) represents a likely takeover target some time this year since the bid from Wyeth (WYE) fell through after the Pfizer (PFE) deal. Crucell offers a technology platform , development pipeline , marketed vaccines , a specialized sales force, and in-house manufacturing facilities.
 
<> As a component in the ETF Innovators Preventive Medicine Index , CRXL is also poised to benefit from a trend in healthcare to increase resources toward preventing disease as a way ...
By  Mike Havrilla   (+1.04%  risk: conservative)  01/30/09 Comment


New Preventive Medicine Index Graphic_rating_buy CRXL
Mikerun
73%
 +0.73%
in 5 days
(closed on 01/30/09)
One of the major reasons behind Pfizer's (PFE) interest in acquiring Wyeth (WYE) is the latter's focus on products outside of traditional pharmaceuticals – with 60% of Wyeth's revenue from last year derived from biological therapeutics and vaccines. It remains to be seen what happens to Wyeth's proposed deal to acquire Dutch vaccine maker Crucell (CRXL); however since it is much smaller (around $1B) and focuses on the development of vaccines, Pfizer would likely be interested in both companies together.
 
<> With the focus on preventive medicine likely continue in the form of co...
By  Mike Havrilla   (+1.04%  risk: conservative)  01/25/09 Comment




From the Blogosphere

Before the bell: Investors bullish ahead of new reports

Filed under: Pfizer (PFE), Walt Disney (DIS), Johnson and Johnson (JNJ), Abbott Laboratories (ABT)

Stocks are expected to open modestly higher on Wall Street after a losing week last week. On Friday, stocks fell for the third straight day after reports on new-home sales and durable goods proved weaker than expected, leading investors to believe the economy has not yet emerged from the recession.

Stocks to watch today include pharmaceutical giant Johnson & Johnson (NYSE: JNJ), which agreed Monday to buy an 18% stake in European drug maker Crucell (NASDAQ: CRXL) for 301.8 million euros ($44...
By  David Schepp   (+0.00%)  09/28/09 Comment


Swine Flu Stocks Watchlist

swine flue epidemic

Once again swine flu is causing headlines and the mobilization of health professionals and the government in combating it. Again? In 1976 President Gerald Ford put into motion a massive vaccination effort to halt the spread of swine flu on the advice of medical experts. About 40 million Americans were inoculated before the program was stopped.

While death is tragic, it isn’t helpful to sensationalize what is happening. For example:

<><>…CDC scientists estimate that an average of 36,000 people (up from 20,000 in previous estimates) die from influenza-related complications each year in the United<><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><>< /><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><><>< /><>< />< />...
By  Trader's Narrative   (+0.00%)  04/30/09 Comment


Analyst upgrades, downgrades and initiations: BKC, NOC, RTN, CMCSA ...

Filed under: Analyst reports, Analyst upgrades and downgrades, Comcast Cl'A' (CMCSA), Kohl's Corp (KSS), Burger King Hldgs (BKC), Analyst initiations, Northrop Grumman (NOC)

Analyst upgrades:
<>
  • RW Baird upgraded LHC Group (NASDAQ: LHCG) to Outperform from Neutral based on valuation and expectations for raised 2009 guidance. The firm has a $36 target on the stock.
  • Deutsche Bank upgraded Swiss Reinsurance (OTC: SWCEY) to Buy from Hold following the CEO change as the firm views it as a positive move.
    • <>Wachovia upgraded DuPont Fabros (NYSE: DFT) to Outperform from Market Perform because ...
    By  Eric Buscemi   (+0.00%)  02/12/09 Comment


    Healthcare Investing Trends for '09 and Beyond
    Mikerun
    73%
    While the departure of Tom Daschle and concerns over rising unemployment and the global economic slowdown may hamper many of President Obama's plans for healthcare reform; there are several growth trends within the sector outlined below which are poised to benefit in 2009 and beyond. Follow any of the links below for more information on the new ETF Innovators indexes and exchange-traded fund ideas for the sector.

    Global Health IT: The top five rated companies include Swiss telemedicine firm Card Guard (CDGUF) – a provider of remote patient monitoring systems, Merge Healthcare (MRGE) – a < />< />< />< /><>< />< />< />< /><><>< />< /><>< />< /><>< />< /><><><>< /><><>< /><>< /><>< /><>< /><>< /><>< /><>< /><>< /><>< /><>< />< />...
    By  Mike Havrilla   (+1.04%  risk: conservative)  02/07/09 Comment


    Crucell: An Excellent Shot at a Buyout
    Mikerun
    73%
    As the largest pure-play vaccine company with a market cap of $1.2B (U.S. Dollar), Crucell (CRXL) represents a likely takeover target some time this year since the bid from Wyeth (WYE) fell through after the Pfizer (PFE) deal. Crucell offers a technology platform, development pipeline, marketed vaccines, a specialized sales force, and in-house manufacturing facilities.

    As a component in the ETF Innovators Preventive Medicine Index, CRXL is also poised to benefit from a trend in healthcare to increase resources toward preventing disease as a way to reduce the cost and complications of treatin...
    By  Mike Havrilla   (+1.04%  risk: conservative)  01/30/09 Comment



    ROCK-STAR INVESTORS
    Rank Name Sharpe Ratio Avg Return Followers
    1 noshoes 21.10 +35.25% 368
    2 Gerald Greene 18.14 +70.90% 206
    3 stockmarketfunding.com 17.66 +25.78% 53
    4 akiralegrand 13.47 +14.32% 60
    5 anup2104 12.13 +69.23% 34


    POPULAR STOCKS
    Symbol Company Name Sentiment
    FSLR First Solar Inc.
    SIRI Sirius Satellite Radio Inc
    POT Potash Corp. of Saskatchewan Inc.
    MSFT Microsoft Corp
    PG The Procter & Gamble Company
    INTC Intel Corp

    TODAY'S HEADLINES

    TODAY'S TOP PICKS

    		 

    StreetInsider.com on CRXL

    Visit streetinsider.com


    Discussion Wall + Add  

    Be the first to start a discussion and earn 2 points.



    More Resources

    Graphic_arrow1 About Crucell NV - Answers.com

    Graphic_arrow1 Historical Prices - Yahoo

    Graphic_arrow1 Message Boards - BoardCentral.com

    Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




    		IN THE PRESS
    Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch